Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Foeldvari

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Rheumatology|January 17, 2002
Anti-keratin antibodies in patients with JIAI Foeldvari
Clinical and Experimental Rheumatology|July 15, 2000
Results of a multi-national survey regarding a feasibility study for a therapeutic trial in juvenile systemic sclerosisI Foeldvari
Clinical and Experimental Rheumatology|January 1, 1997
Juvenile rheumatoid arthritis, Crohn's disease and Turner's syndromeI Foeldvari
Arthritis and Rheumatism|February 20, 1999
Do we need pediatric rheumatologists? The Hamburg, Germany experienceI Foeldvari
Current Opinion in Rheumatology|September 16, 2000
Diffuse and limited cutaneous systemic sclerodermaI Foeldvari
Rheumatology (Oxford, England)|September 22, 2006
Systemic sclerosis in childhoodI Foeldvari
Clinical and Experimental Rheumatology|January 2, 2003
A selective COX-2 inhibitor, meloxicam, as a treatment option in patients with juvenile idiopathic arthritis and gastrointestinal side effects from naproxenI Foeldvari
The Journal of Pediatrics|August 26, 1998
Progressive linear scleroderma and morphea in a childI Foeldvari
The Journal of Rheumatology|April 27, 2000
Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for RheumatologyI Foeldvari, M Bidde
Paediatric Drugs|October 2, 2001
Recognition and management of scleroderma in childrenI Foeldvari, N Wulffraat
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Rheumatology|January 17, 2002
Anti-keratin antibodies in patients with JIAI Foeldvari
Clinical and Experimental Rheumatology|July 15, 2000
Results of a multi-national survey regarding a feasibility study for a therapeutic trial in juvenile systemic sclerosisI Foeldvari
Clinical and Experimental Rheumatology|January 1, 1997
Juvenile rheumatoid arthritis, Crohn's disease and Turner's syndromeI Foeldvari
Arthritis and Rheumatism|February 20, 1999
Do we need pediatric rheumatologists? The Hamburg, Germany experienceI Foeldvari
Current Opinion in Rheumatology|September 16, 2000
Diffuse and limited cutaneous systemic sclerodermaI Foeldvari
Rheumatology (Oxford, England)|September 22, 2006
Systemic sclerosis in childhoodI Foeldvari
Clinical and Experimental Rheumatology|January 2, 2003
A selective COX-2 inhibitor, meloxicam, as a treatment option in patients with juvenile idiopathic arthritis and gastrointestinal side effects from naproxenI Foeldvari
The Journal of Pediatrics|August 26, 1998
Progressive linear scleroderma and morphea in a childI Foeldvari
The Journal of Rheumatology|April 27, 2000
Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for RheumatologyI Foeldvari, M Bidde
Paediatric Drugs|October 2, 2001
Recognition and management of scleroderma in childrenI Foeldvari, N Wulffraat
Pageof 5